Pfizer Asks FDA to Authorize COVID-19 Vaccine Booster Shots for All Adults
Summary from the AllSides News Team
Pharmaceutical company Pfizer announced Tuesday that it's asking the Food and Drug Administration (FDA) to authorize its COVID-19 vaccine booster shot for all Americans ages 18 and up.
An FDA advisory panel rejected a similar request from the company in September, and a third dose of the company's vaccine was authorized only for certain adults by federal regulators soon after. Pfizer and its partner BioNTech say the booster shot is over 95% effective against infection. The FDA will consider the request, but it’s not clear if an advisory panel will debate it as well. Booster shots are currently authorized for people who are 65 and older, who have underlying conditions, or who work jobs that put them at higher risk for COVID-19.
The news was covered similarly across the spectrum. Left- and center-rated outlets featured their coverage of it more prominently on their sites and across social media. Right-rated sources typically focused more on the FDA panel's prior rejection of the request and advisors who were skeptical of the need for all adults to get boosters.
Featured Coverage of this Story
From the Left
Pfizer asks for FDA authorization for booster for everyone 18 and up
Pfizer-BioNTech asked the Food and Drug Administration on Tuesday for emergency use authorization for its Covid-19 booster shot for all adults ages 18 and up, a move the company has been angling for over the past several months.
Pfizer’s request will now be considered by the FDA, which will make a final decision in the coming weeks. It’s unclear whether the agency will ask its independent advisory group, called the Vaccines and Related Biological Products Advisory Committee, to offer guidance on authorizing the booster.
Pfizer’s booster shot is currently authorized for certain...
From the Center
Pfizer asks FDA to authorize booster shot for all adults
Pfizer and BioNTech on Tuesday said they had asked the Food and Drug Administration (FDA) to authorize booster shots of their COVID-19 vaccine for all adults 18 and over, seeking to broaden who is eligible for a third shot.
The move comes as part of a long-running debate among experts over who should be eligible for booster shots. An FDA advisory panel voted against a request for all adults to have a booster in September, in what was a blow to the Biden administration's earlier announcement of widespread shots.
But the...
From the Right
Pfizer Asks US Regulators to Authorize COVID-19 Vaccine Boosters for All Adults
Pfizer wants clearance for booster shots of its COVID-19 vaccine for all American adults, the company announced Tuesday.
Rebuffed in September by experts on a Food and Drug Administration (FDA) vaccine advisory panel, the company is trying again, pointing to data from a recent trial examining the safety and efficacy of boosters in a more than 10,000 people 16 or older.
The trial showed that a third dose of Pfizer’s jab boosted efficacy to 95.6 percent, Pfizer and its partner BioNTech said, much higher than the effectiveness seen recently in real-world settings....
AllSides Picks
May 12th, 2024
May 12th, 2024
May 9th, 2024
More News about Coronavirus from the Left, Center and Right
From the Left
From the Center
From the Right
